$GTH News
Last published 2y ago
- 2y agoGTHGenetron Health Announces Completion of Going Private TransactionGlobeNewswireBEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular
- 2y agoGTHGenetron Health Announces Shareholders' Approval of Merger AgreementGlobeNewswireBEIJING, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular
- 2y agoGTHGenetron Health to Hold Extraordinary General Meeting of ShareholdersGlobeNewswireBEIJING, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular
- 3y agoGTHGenetron Health Enters into Definitive Merger Agreement for Going Private TransactionGlobeNewswireBEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular
- 3y agoGTHGenetron Health Announces Receipt of Notification from NasdaqGlobeNewswireBEIJING, May 23, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ((", Genetron Health", or the ", Company", , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in
- 3y agoGTHGenetron Health Regains Compliance With Nasdaq Minimum Bid Price RequirementGlobeNewswireBEIJING, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ((", Genetron Health", or the ", Company", , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in
- 4y agoGTHGenetron Health Announces Receipt of Notification from NasdaqGlobeNewswireBEIJING, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ((", Genetron Health", or the ", Company", , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in
- 4y agoGTHGenetron Health Reports Unaudited Second Quarter 2022 Financial ResultsGlobeNewswireBEIJING, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ((", Genetron Health", or the ", Company", , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in
- 4y agoGTHGenetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special CommitteeGlobeNewswireBEIJING, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 4y agoGTHGenetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the CompanyGlobeNewswireBEIJING, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health to Participate in the Goldman Sachs Healthcare Corporate DayGlobeNewswireBEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health Receives CAP Accreditation for its Maryland LaboratoryGlobeNewswireBEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health Reports Unaudited First Quarter 2022 Financial ResultsGlobeNewswireBEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewswireBEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-GenesGlobeNewswireBEIJING, June 01, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022GlobeNewswireBEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening
- 4y agoGTHGenetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD®GlobeNewswireBEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 4y agoGTHGenetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022GlobeNewswireBEIJING, April 08, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 4y agoGTHPublication in Clinical and Translational Medicine Demonstrates Mutation Capsule™'s potential in MRD Assay DevelopmentsGlobeNewswireBEIJING, April 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 4y agoGTHGenetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswireBEIJING, March 29, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 4y agoGTHGenetron Health to Participate in the Credit Suisse Asian Investment ConferenceGlobeNewswireBEIJING, March 21, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 4y agoAGTHArima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational ApplicationsBusiness WireArima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ:GTH), Tech Coast Angels, Ladder Ventures, and Hiaqua Investments were joined by
- 4y agoGTHGenetron Health to Announce Fourth Quarter and Full Year 2021 Unaudited Financial Results and Host Investor Call on March 29, 2022GlobeNewswireBEIJING, March 09, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 4y agoGTHGenetron Health Announces Companion Diagnostic Collaboration Agreement with HUTCHMED's ORPATHYS® for NSCLCGlobeNewswireBEIJING, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health to Participate in Upcoming Investor ConferencesGlobeNewswireBEIJING, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health Reiterates Full Year 2021 Revenue GuidanceGlobeNewswireBEIJING, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health's Social Contribution Campaign to Make Precision Medicine More AccessibleGlobeNewswireBEIJING, Dec. 13, 2021 (GLOBE NEWSWIRE) -- (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion d
- 4y agoGTHNEOGenetron Health Reports Third Quarter 2021 Unaudited Financial ResultsGlobeNewswireBEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoAZNGTHGenetron Health Announces Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in ChinaGlobeNewswireBEIJING, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health Reveals Two Cancer Research Study Results at the Association for Molecular Pathology 2021 Annual MeetingGlobeNewswireBEIJING, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health to Participate in the 8th BioCentury-BayHelix China Healthcare SummitGlobeNewswireBEIJING, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 4y agoGTHGenetron Health Announces Publication of Enhanced Variant Caller Performance Data in Briefings in BioinformaticsGlobeNewswireBEIJING, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer screening product
- 5y agoGTHNEOGenetron Health Establishes Strategic Partnership with NeoGenomics to Drive Global Oncology Drug Research and DevelopmentGlobeNewswireBEIJING, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHGenetron Health to Announce Third Quarter 2021 Financial Results and Host Investor Call on November 30, 2021GlobeNewswireBEIJING, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHGenetron Health's Multi-Gene Mutation Detection Kit Onco PanScan™ Obtains CE MarkGlobeNewswireBEIJING, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company") (NASDAQ:GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening product
- 5y agoGTHGenetron Health Wins Second Prize of China's National Science and Technology Progress Award for Contributions to Lung Cancer Precision Medicine ProjectGlobeNewswireBEIJING, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company") (NASDAQ:GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening product
- 5y agoGTHGenetron Health's Liver Cancer Screening Results and Technology Findings Included in the Chinese Journal of HepatologyGlobeNewswireBEIJING, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company") (NASDAQ:GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening product
- 5y agoGTHGenetron Health and Fosun Pharma Announce Exclusive Partnership to Commercialize Seq-MRD® in ChinaGlobeNewswireSHANGHAI, China, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer screening
- 5y agoGTHGenetron Health and IMPACT Therapeutics Announce Partnership to Drive Development of Synthetic Lethal Product PipelineGlobeNewswireBEIJING, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screeni
- 5y agoGTHGenetron Health Unveils 13 Cancer Research findings at ESMO Congress 2021GlobeNewswireBEIJING, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer screening produc
- 5y agoGTHGenetron Added to FTSE Russell Global Equity Index SeriesGlobeNewswireBEIJING, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), today announced that Genetron will be added to the below FTSE Global Equity Index Series ("GEIS"), following FTSE's most recent qua
- 5y agoGTHGenetron Health's Co-Founder and Chief Scientific Officer Awarded International Prize for Translational Neuroscience 2021GlobeNewswireBEIJING, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer screening product
- 5y agoGTHGenetron Health Reports Second Quarter 2021 Unaudited Financial ResultsGlobeNewswireBEIJING, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHGenetron Health to Host Calls Following Earnings and Participate in an Upcoming Investor ConferenceGlobeNewswireBEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHGenetron Health Reaches Strategic Partnership with Yikon Genomics, Expanding S5 Platform's Reach to Reproductive Health FieldGlobeNewswireBEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHGenetron Health to Announce Second Quarter 2021 Financial Results and Host Investor Call on August 24, 2021GlobeNewswireBEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHGenetron Health Tops NCCL's External Quality Assessment of NGS-based Comprehensive Genomic Profiling for Solid Tumors with Full MarksGlobeNewswireBEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHGenetron Health Partners with Guizhou Province's Dafang County to Lead Liver Cancer Early Screening ProjectGlobeNewswireBEIJING, July 29, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screenin
- 5y agoGTHAYVAKIT® (avapritinib) Companion Diagnostic Test Enters Priority Review and Approval Process in ChinaGlobeNewswireBEIJING, July 26, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), today announced that its AYVAKIT® (avapritinib) companion diagnostic (CDx) kit, developed in partnership with CStone Pharmaceutical
- 5y agoGTHGenetron Health Receives CE Mark for 8-Gene Lung Cancer Assay and Provides FDA Reference Panel Comparative Data of its SARS-CoV-2 RNA TestGlobeNewswireBEIJING, July 13, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer screening product